Project Details
Description
A Double-Blind Placebo Controlled Trial of Intravenous OvaRex Mab-B43 as Post Chemotherapy Consolidation for Ovarian
Status | Finished |
---|---|
Effective start/end date | 12/1/98 → 11/30/08 |
Funding
- UNITHER PHARM INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.